Xin Sun

Apatinib plus camrelizumab (anti-PD1 therapy, SHR-1210) for advanced osteosarcoma (APFAO) progressing after chemotherapy: a single-arm, open-label, phase 2 trial

Lu Xie, Jie Xu, Xin Sun et al. · Journal for ImmunoTherapy of Cancer · 2020 · 150 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial

Lu Xie, Jie Xu, Xin Sun et al. · The Oncologist · 2018 · 128 citations · Full text

Medicine, Oncology, Pharmacology +17

Prognostic factors in osteosarcoma: A study level meta-analysis and systematic review of current practice

Xin Sun, Guo Wei · Journal of bone oncology · 2020 · 106 citations · Full text

Medicine, Oncology, Surgery +17

Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients

Jun Wang, Hongliang Zhang, Xin Sun et al. · Journal of Nanobiotechnology · 2020 · 86 citations · Full text

Medicine, Immunology, Oncology +17

Outcome of surgical treatment of pelvic osteosarcoma

Wei Guo, Xin Sun, Tao Ji et al. · Journal of Surgical Oncology · 2012 · 46 citations

Medicine, Orthopaedic Surgery, Surgery +17